The global Antibody Drug Conjugate Market size is expected to reach USD 9.93 billion by 2025, according to a new report by Grand View Research, Inc. it is projected to expand at a CAGR of 25.9% over the forecast period. Increasing ... Read more
Antibody drug conjugates (ADCs) are a new class of biopharmaceutical drug containing an antibody with to a biologically active drug. They are designed to eliminate the tumor after being released in the bloodstream to target cancerous cells. The global Antibody Drug Conjugate Market Growth report by Market Research Future (MRFR) contains in detail the effects of ADCs as well as the large potential in medical applications.
